Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Connock

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|April 4, 2009
Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysisDavid Moore, Paul Aveyard, Martin Connock, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 7, 2009
Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinencePaul Aveyard, Dechao Wang, Martin Connock, et al.
Journal of Market Access & Health Policy|September 7, 2019
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myelomaXavier Armoiry, Hans-Martin Spath, Aileen Clarke, et al.
Expert Opinion on Biological Therapy|December 28, 2020
Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICEXavier Armoiry, Hans-Martin Späth, Anna-Maria Henaine, et al.
Plos One|June 16, 2012
The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysisClare Stradling, Yen-Fu Chen, Tracy Russell, et al.
BMJ Open|March 14, 2023
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical riskMartin Connock, Peter Auguste, Aude Capelle, et al.
The British Journal of Ophthalmology|January 15, 2015
Extending the diabetic retinopathy screening interval beyond 1 year: systematic reviewSian Taylor-Phillips, Hema Mistry, Rachael Leslie, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Vaccine|November 22, 2005
Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidenceRachel Jordan, Martin Connock, Esther Albon, et al.
BMC Cancer|April 27, 2019
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trialsMartin Connock, Xavier Armoiry, Alexander Tsertsvadze, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|April 4, 2009
Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysisDavid Moore, Paul Aveyard, Martin Connock, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 7, 2009
Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinencePaul Aveyard, Dechao Wang, Martin Connock, et al.
Journal of Market Access & Health Policy|September 7, 2019
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myelomaXavier Armoiry, Hans-Martin Spath, Aileen Clarke, et al.
Expert Opinion on Biological Therapy|December 28, 2020
Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICEXavier Armoiry, Hans-Martin Späth, Anna-Maria Henaine, et al.
Plos One|June 16, 2012
The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysisClare Stradling, Yen-Fu Chen, Tracy Russell, et al.
BMJ Open|March 14, 2023
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical riskMartin Connock, Peter Auguste, Aude Capelle, et al.
The British Journal of Ophthalmology|January 15, 2015
Extending the diabetic retinopathy screening interval beyond 1 year: systematic reviewSian Taylor-Phillips, Hema Mistry, Rachael Leslie, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Vaccine|November 22, 2005
Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidenceRachel Jordan, Martin Connock, Esther Albon, et al.
BMC Cancer|April 27, 2019
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trialsMartin Connock, Xavier Armoiry, Alexander Tsertsvadze, et al.
Pageof 5